News
Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...
Pfizer (PFE) and Arvinas (ARVN) aim to seek FDA approval for thier breast cancer therapy vepdegestrant in H2 2025. Read more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback